Driven by innovation and investment, some of the world’s leading biotech, bioscience, and pharmaceutical companies have already made North Fulton their home — contributing to the $27 billion economic impact the life science industry generates across Georgia.
Boston Scientific, a Massachusetts-based, minimally invasive healthcare technology company with close to 60,000 employees across six continents, invested $108 million in Johns Creek, opening a 200,000-square-foot manufacturing and research facility in 2025 that now employs close to 300.
Kuros Bioscience, a Swiss biotechnology company specializing in spinal fusion biologics, operates its major U.S. headquarters in Roswell and began leasing a 50,000-square-foot manufacturing facility there in 2025, with plans for a larger long-term base.
Boehringer Ingelheim, one of the largest pharmaceutical companies manufacturing products in Georgia, leads in animal health innovation from its 73,000-square-foot office in Medley, Johns Creek’s premier 42-acre mixed-use community. The facility is soon to become the company’s U.S. Animal Health headquarters, and will employ nearly 500 in 2026.
Additional pharmaceutical companies, including Acella and Avion Pharmaceuticals, also do business in Alpharetta, GA, producing everything from cough formula and dermatology products to nutritional and prenatal supplements.
